Insider Trading History of Davis Thomas Andrew

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Davis Thomas Andrew since 2006. This trader's CIK number is 1338185. At the time of last reporting, Davis Thomas Andrew was the CHIEF MEDICAL OFFICER of Genocea Biosciences, Inc.. (stock ticker symbol GNCA). Also see all insider trading activities at Genocea Biosciences, Inc..

Note that in the past Davis Thomas Andrew also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Genocea Biosciences, Inc. (GNCA) by Davis Thomas Andrew

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 GNCA 0 $0 3,808 $4,351 0 $0

Yearly summary of insider trading at Genvec Inc (GNVC) by Davis Thomas Andrew

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2005 GNVC 5,000 $9,100 0 $0 0 $0

Yearly summary of insider trading at Celldex Therapeutics, Inc. (CLDX) by Davis Thomas Andrew

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 CLDX 2,500 $9,437 0 $0 0 $0


Insider trading activities at 3 companies by Davis Thomas Andrew:

1. Genocea Biosciences, Inc. (GNCA)

2. Genvec Inc (GNVC)

3. Celldex Therapeutics, Inc. (CLDX)

Table 1. Insider trading of Genocea Biosciences, Inc. (GNCA) by Davis Thomas Andrew

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-04-04 GNCA Sale 1,091 1.25 1,363
2022-03-16 GNCA Sale 2,717 1.10 2,988

Table 2. Insider trading of Genvec Inc (GNVC) by Davis Thomas Andrew

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2005-11-22 GNVC Buy 5,000 1.82 9,100

Table 3. Insider trading of Celldex Therapeutics, Inc. (CLDX) by Davis Thomas Andrew

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-09-16 CLDX Buy 2,500 3.77 9,437

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Davis Thomas Andrew (CHIEF MEDICAL OFFICER of Genocea Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.